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ABSTRACT

South Florida has had the largest number of U.S. Zika infection cases during the recent outbreak.
This study aimed at assessing South Floridians’ basic knowledge, perceptions of the seriousness
and susceptibility to Zika infection, their information sources and needs, as well as their attitudes
towards the protective measures proposed by the CDC. We also wanted to assess whether any of
those factors have affected the frequency of participants’ undertaking of the protective behaviors.
To this end, we designed an online questionnaire and surveyed the responses of five hundred
South Floridians (Age=18-78 years). We found significant gaps in participants’ knowledge about
the risk groups, routes of transmission, treatment, and complications of Zika infection. Older age
and college education were associated with significantly higher knowledge scores, while the
presence of pregnant women in the household was associated with lower scores. About half of
the participants perceived Zika to be a profoundly severe health problem, but less than one-third
believed that their susceptibility to the infection is high.
Most participants agreed that undertaking the measures that limit exposure to mosquito bites
would be effective in preventing infections and that they would be able to carry-out these
measures if recommended by the CDC, but a significantly lower proportion had similar
responses to the items regarding protection against sexual transmission.
There was a significant association between the frequency of protective behavior undertaking
and respondents’ beliefs about the seriousness and personal susceptibility to the infection, as well
as their beliefs regarding the efficacy of the protective behaviors.
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Finally, most participants reported media platforms as their sources of information about Zika,
while a minority of them received their information directly from healthcare professionals.
These findings suggest that more targeted risk communication efforts are needed to increase
South Floridians’ awareness about Zika’s public health threat.
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INTRODUCTION
Biology
Zika virus (ZIKV) is an arbovirus that belongs to the genus Flavivirus of the family Flaviviridae
[1]. Other members of this genus include the Yellow fever, Dengue, Chikungunya and West Nile
viruses[2] .
Cryo-microscopic analysis showed that although Zika shares a similar overall structure to that of
other Flaviviruses, it exhibits some differences that might explain its specific cellular tropism
and unique ability to survive in the acrid conditions of various body fluids for long periods of
time [3]. For instance, the different amino acid sequence surrounding the glycosylation site of
Asn154 in the envelope protein of ZIKV when compared to other Flaviviruses could influence its
predilection for targeting neural progenitor cells [4]. Moreover, Cryo-EM showed that ZIKV
possesses a more compact surface and is more thermally stable than other Flaviviruses[3]..
However, a recent research reported that, under physiological conditions, ZIKV has not been
found to be uniquely heat stable in comparison to other Flaviviruses, thereby putting the
previously proposed pathobiological mechanism into question[5].
ZIKV is a Positive-sense single-stranded RNA virus [6]. Its 10,794 nucleotides-long genome
contains regions that encode a single polypeptide of about 3419 amino acids flanked by 5’ and 3’
UTRs[7]. The single polypeptide is cleaved by viral and host proteases to produce three
structural proteins (Envelope [E], Core [C], Precursor of membrane [prM]) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5)[8].The non-structural
proteins play important roles in viral assembly and replication, as well as in circumventing the
immune response of the host[9].
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Following binding of viral E protein to surface receptors of the host cell, the Virion gains entry
into the host cell through receptor-mediated endocytosis[10]. The low pH inside the endosome
triggers a conformational change in the viral surface proteins, with subsequent fusion of viral and
endosomal membranes[10]. Viral genome is then released into the host cell cytoplasm, and is
translated at the surface of the ER[10]. The immature Virion assembles at the ER, and then is
transported to the Golgi apparatus. Finally, Virion maturation takes place at the trans-Golgi
apparatus when the prM protein is proteolytically modified, and the mature viral particle is
released by exocytosis [10].
Phylogenetic analysis showed that ZIKV strains can be divided into two lineages: Asian and
African[11] . The strains isolated during the recent outbreak belong to the Asian lineage [12].
The African lineage was found in cell culture studies to be more virulent and to cause higher
rates of early cell death than the Asian counterpart[13]. This milder inflammatory response might
provide an explanation for the ability of the Asian lineage strains to cause persistent infections of
fetal neural progenitor cells following trans-placental infection[14].

Routes of Transmission
The virus is mainly transmitted to humans through the bite of the mosquito species: A. aegypti
and A. albopticus . These mosquitoes are also the vectors transmitting other flavivirus infections,
such as Dengue and yellow fever [15]. ZIKV has also been isolated from other Mosquito species,
but their competence as vectors for transmission to humans is yet to be confirmed [16]. In
addition to the vector-borne infection, human to human transmission can also occur. Sexual
transmission is a well-recognized route of ZIKV transmission[17, 18]. The virus is shed in
2

vaginal secretions and in semen, where it can be detected for several months after the acute
infection [19]. It’s also secreted in other body fluids, but there isn’t sufficient evidence
supporting transmission via those routes, except for transmission through infected blood[20, 21].
Also, the virus can be transmitted from a pregnant woman to her fetus either trans-placentally or
through contact with vaginal secretions during delivery[22, 23].

Diagnosis & Screening
Viral RNA can be detected in patients’ serum for about seven days after the onset of symptoms
using RT-PCR [24]. The same technique can be used to detect viral particles in other body fluids,
such as urine and semen, where they can be detectable for longer periods than in serum samples
[25, 26]. Another possible approach to the diagnosis is by using ELISA kits that detect
antibodies against viral proteins. IgM levels can be detectable in serum for up to twelve weeks
following the onset of symptoms, and IgG levels can be detected as early as two weeks after the
fever onset[24]. While this method is quick and easy, due to the cross-reactivity of those
antibodies with other Flaviviruses, a positive test must be confirmed using plaque reduction
neutralization test [27].
The CDC recommends screening for all pregnant women with possible exposure to ZIKV
regardless of the presence of symptoms, and to all symptomatic patients with possible exposure
[28].
Treatment
There has been a lot of research over the past two years aiming at finding potential therapeutics
for Zika infections. Most of these projects utilized compounds that were previously approved for
3

other purposes, and some of these drugs showed good efficacy in vitro and in animal studies[29,
30]. However, as of now, there is no approved specific treatment for Zika infection, and
treatment is symptomatic. Acetaminophen can be used to ameliorate the fever and pain in
symptomatic patients[31]. But Aspirin, Ibuprofen, and other NSAIDs should be avoided in
suspected cases of Zika infection. This is because their use in other Flavivirus infections has
been associated with hemorrhagic syndromes [32].

Complications
Congenital Infection
Zika infection during pregnancy can be detrimental to the developing fetus, particularly if the
infection is acquired during the first trimester, the period of Organogenesis. The system that is
most commonly reported to be affected in congenital Zika infections is the nervous system.
ZIKV is neurotropic, with preference for targeting neural progenitor cells [33]. This damage
might be attributed to the hyper-activation of TLR 3-mediated immune response, which is known
to be a negative regulator of neural progenitor cells’ growth [34]. Also, Some Bioinformatics
data suggested a similar role for Retinoic acid response elements [35]. The resulting defective
brain development can manifest clinically as Microcephaly, defined as a head circumference
that’s less than two standard deviations below the mean for age, sex, and race [36]. Also, there
have been case reports of other neurological manifestations of congenital Zika infection, such as:
vision and hearing impairment, abnormal muscle tone and exaggerated reflexes [37, 38]. In
addition, congenital Zika infection has been associated with intra-uterine growth restriction
(IUGR), pulmonary hypoplasia, and stillbirths [39] . While it is still early to assess the full
4

spectrum of long-term complications of congenital Zika infection in humans, experimental
animal studies indicate that the virus can cause testicular damage, which subsequent impaired
fertility in males [40].

Guillain-Barré Syndrome (GBS)
Another complication that might follow Zika infection in any age group is GBS [41]. It is an
autoimmune disease in which antibodies attack the myelin sheaths of peripheral nerves [42].
Clinically, patients present with rapidly progressive ascending muscle weakness and diminished
deep tendon reflexes [42]. The most dreadful manifestation of GBS is paralysis of the
Diaphragm, which requires management with mechanical ventilation in the intensive care unit
[43].

Prevention
Several Zika vaccines that have been developed over the past few years showed promising
results in animal studies, and some of them are in the clinical trials phases [44]. These vaccines
were generated using methods similar to the previously used techniques for developing vaccines
against other Flaviviruses. Vaccine candidates that are in clinical trials include: a live-attenuated
vaccine, a DNA-based vaccine, A purified inactivated viral vaccine, mRNA based and viral
vector-based vaccines [45]. Until such vaccines become approved for human use, prevention is
based on vector control, limiting exposure to mosquito bites, safe sexual practices, and screening
of donated blood before use [46].

5

History
The virus was named after the Ugandian forest in which it was isolated in 1947 from the serum
of Rhesus monkeys [47]. A year later, the mosquito species (A. africanus) was identified as a
vector for transmission [47].
Antibodies against ZIKV were found in serum samples from residents of several countries in
equatorial Africa in the following decades [48-50]. However, only mild febrile illnesses were
reported in those patients, and none of the infected individuals required hospitalization[51].
In the late 1960s, the virus was isolated from the mosquito species A.aegypti in tropical Asian
regions [52].
The first major documented Zika outbreak occurred in 2007, when an estimated 73% of the
population of the Pacific Yap islands in the Federated States of Micronesia were infected [53].
The reason that such an outbreak occurred in the Pacific instead of Asia or Africa might be
because the regular exposure to the infection in endemic regions has prevented outbreaks [51] .
Also, since the clinical presentation of Zika infection is similar to that of other Flavivirus
infections, which are endemic in equatorial Africa and Asia, Zika outbreaks in these regions
might have been misdiagnosed as Dengue or Chikungunya infections [51].
In 2013, the second major outbreak occurred in French Polynesia, during which 49% of its
population were infected [54]. A 20-fold increase in the incidence of GBS was documented in
French Polynesia at the same period, and two cases of perinatal transmission were also reported
during this outbreak [22, 55].
Over the following two years, multiple small-scale outbreaks were documented in other Pacific
islands [56].
6

The Recent Outbreak
In the Americas
The recent outbreak started in Brazil early on 2015, and then spread to other countries in the
Americas [57-59]. By the end of 2015, Brazilian health authorities estimated that between
400,000 and 1,300,000 infection cases occurred in the country [60].
The outbreak was associated with a great increase in the incidence of Microcephaly and GBS in
the affected regions, which led the WHO on Feb-2016 to declare Zika as a Public Health
Emergency of International Concern [41, 61, 62].
WHO’s advisory report recommendations included delaying travel to areas with active virus
transmission , and safe sexual practices or sexual abstinence for pregnant women who live in
these regions [62]. The director-general of the WHO declared on November 2016 the end of the
Public Health Emergency of International Concern; emphasizing that Zika infection and its
complications remain a significant health challenge that needs a long-term program of work [63].
In the United States
Between 2015 and (January 10, 2018), 5,635 symptomatic ZIKV infection cases were recorded
in the U.S., and another 37,123 were recorded in U.S. territories [64]. Most cases in the U.S.
were travel related, while the majority of cases in U.S. territories were locally acquired [64].
Among the confirmed infection cases were about 7,000 in pregnant women [65]. Zika-associated
birth defects were observed in about 10% of pregnancies with laboratory-confirmed infections
[64, 66].
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In Florida
96% of the local mosquito-borne Zika infections in the U.S. were in Florida [64]. Four regions in
the state’s south had active local transmission in 2016, and Miami-Dade County was designated
as a Zika cautionary travel region until June 2, 2017 [67, 68].
Recent research indicated that the virus was probably introduced to South Florida via travelers
from the Caribbean [69]. The high incidence rate in Miami-Dade might be attributed to the local
abundance of A.aegypti in the county, combined with the fact that Florida received more visitors
from Zika endemic regions than any other state in the past few years [69].

Because of the unavailability of protective vaccines against Zika so far, the public health strategy
in the United States has been to fund research aimed at developing vaccinations and to initiate
aggressive vector control campaigns, in addition to targeted risk communication[70].
According to the UNICEF’s guidelines, Zika risk communication and community engagement
campaigns should be based on research assessing public risk perceptions and attitudes towards
the protective behaviors[71]. The guidelines also recommend that the communication be tailored
to the specific needs of different population groups[71]. The aim of this research was to assess
the basic knowledge and risk perceptions regarding the recent Zika outbreak in a sample of
South Florida residents, their information sources and needs, as well as their beliefs about the
efficacy of the proposed protective measures. We also wanted to assess which of these factors, if
any, have affected participants’ undertaking of the protective behaviors.
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METHODS

Survey Design and Administration

The initial questionnaire was adapted from two previously published survey design guides [72,
73]. Then, the questions were sent to 25 UCF faculty members and graduate students for
feedback and modified accordingly. An online survey (Click to access) was subsequently
designed using Qualtrics platform. After obtaining UCF’s IRB approval (APPENDIX C: UCF
IRB LETTER), links to the survey were sent to 160 UCF students through emails for pilot
testing. Next, we started recruiting respondents through Qualtrics Panel Services team. 500
participants from South Florida who were at least 18 years old were recruited. The amount of
time spent answering the questions was used as a quality control measure, and respondents who
completed the survey in less than 1/3 the average time for completion of other participants were
excluded. Also, a quota was used to get responses with an equal Male: Female distribution. The
recruitment was done in the period between (8/30/2017) and (9/20/2017).

Survey Items
The first page is the informed consent page. On this page, a brief description of the aims and
general structure of the survey is provided, and participants are informed about the procedures
that will maintain the confidentiality and anonymity of their responses. Then, respondents are
asked to confirm that they are at least 18 years old and that they agree to participate in the study.
The next series of questions are about demographics. These include respondents’ age, gender,
9

educational level and residence. In addition, following the suggestions of WHO’s guide,
questions about the number of women of child-bearing age and the number of pregnant women
in the household were included in this section. In the following question, respondents are asked
about the sources of their information about Zika. The (Knowledge) section begins with a
question assessing participants’ subjective evaluation of the sufficiency of their information
about Zika. Then, participants’ basic knowledge is assessed with questions about the risk groups,
routes of transmission, symptoms, treatment, complications of Zika infections, as well as the
availability of a vaccine against the virus. The next section evaluates respondents’ perception of
the seriousness of Zika infection on a scale from 1 to 10 (Perception of severity). To provide a
comparative context, the same question included items for five other diseases, the severity of
which should be familiar to any adult U.S. citizen. Then, respondents are asked to rate the
likelihood that they will get infected with Zika if they do not undertake any protective measure
(Perception of susceptibility). After that, participants are asked about the frequency with which
they undertook the protective measures against Zika that were proposed by the CDC. A fivepoint Likert item format (from NEVER to ALWAYS) was used to assess the frequency of
undertaking for each of the six protective behaviors. Next, Respondents’ beliefs about the
effectiveness of those proposed measures (Response efficacy beliefs), and about their ability to
carry-out those measures (Self-efficacy beliefs) were assessed using Likert items with five-point
scales (From STRONGLY DISAGREE to STRONGLY AGREE). In the final question,
respondents are asked about the information that they want to get about Zika.
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Data Analysis
Intellectus  and SPSS 24 are the softwares that were used for statistical analysis. Tables and
graphs were designed using Microsoft Excel 2016.
Knowledge score was calculated as follows: The questions were divided into six groups, and a
correct answer to each of the groups’ questions was assigned a total score of 1 point. These
question groups included: Risk groups [Q12] (0.16 point for each correct answer choice), Routes
of transmission [Q13] (0.11 point for each correct answer choice), Symptoms (Q14), Treatment
(Q15, Q16) [0.5 point for each question], Complications (Q17, Q18) [0.5 point for each
question] and Vaccination (Q19).
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RESULTS

Descriptive Statistics
Demographics
500 participants from South Florida completed the survey. The female to male ratio was 1:1.
The age range was between 18-78 years old, and about half of the respondents (49%) were
between 18-38 years old (Figure 1). About two-thirds of the participants (61%) have a college
degree, while only 3% haven’t graduated from High School (Figure 2). 58% of those who
completed the survey reported having at least one woman of child-bearing age living in the
household, but only 10% of them had pregnant women in their households(Figure 3,Figure 4).

Knowledge Questions
About two-thirds of the participants (61%) thought that they had enough information about Zika.
However, Objective evaluation revealed significant gaps in their knowledge about the infection.
For instance, an average of 33% of the respondents did not know that humans, other than
pregnant women and their babies, can get infected with Zika (Figure 5). Also, while the vast
majority (96%) correctly identified Mosquito bites as a route of transmission, more than half of
the participants (56%) did not know that the infection can be sexually transmitted (Figure 6).
Most participants (79%) recognized that Zika infections are often asymptomatic (Figure 7). In
terms of treatment,42% of the surveyed mistakenly thought that Antibiotics can treat Zika
infections, and only 32% knew that Aspirin and other NSAIDs should not be used to treat the
pain and fever in Zika suspected cases(Figure 8). Microcephaly was recognized as a possible
12

complication of Zika infection during pregnancy by about 90% of the participants, but 34% of
them didn’t know that the other major complication, Guillain-barré syndrome, can follow Zika
infection regardless of the age and gender of the infected individual (Figure 9, Figure 10).
Another significant misconception among the respondents was with regard to vaccination
availability, with 40% of them mistakenly thinking that there is an FDA-approved vaccine
against Zika infection (Figure 11).
Next, we calculated the proportion of respondents who had misconceptions in each of the
categories of (Knowledge) questions, defined as selecting at least one incorrect answer choice.
The proportion of participants with misconceptions ranged between 20% and 87%, with more
than half of them having misconceptions regarding the risk groups, routes of transmission, and
treatment of Zika infections (Table 1).

Perception of Zika Infection Severity
Of the six diseases we asked about, Zika ranked 3rd in terms of perceived severity, preceded only
by: Having a Heart attack (1st), and contracting HIV infection (2nd). Zika infection severity rating
was similar to that of Diabetes. More than half of the participants (55%) thought that getting
infected with Zika would be a highly serious health problem for them, while only 23% perceived
the infection to be of low seriousness (Figure 12).

Perception of Personal Susceptibility to Zika Infection
Only 16% of the respondents perceived a high personal likelihood for contracting the infection in
the following year, and another half (49%) thought that their chances of getting infected with
13

Zika are low, even without undertaking any measures to protect themselves (Figure 13). The
mean score for the (Perception of susceptibility) question was 4.1/10 (SD= 2.4).

Frequency of Protective Behavior Undertaking
The majority of respondents reported undertaking the Four measures that aim at protecting
against vector-borne transmission at least sometimes since they learned about the recent Zika
outbreak. (range = 63% to 79%). A different result, however, was observed for the behaviors that
target limiting sexual transmission, with more than two-thirds (75% & 70%) of the participants
reporting that they seldom or never have undertaken those measures (Figure 14).

Response Efficacy Beliefs
With the exception of the (Sexual protection) items, the majority of participants agreed that the
proposed measures can protect against Zika infection. The proportion of respondents who
believed that the other four measures can be protective ranged from 66% for the (Wearing longsleeved clothes) item to 82% for the item regarding limiting travel to areas with reported active
transmission (Figure 15).

Self-Efficacy Beliefs
When asked about whether they believe in their ability to carry-out the four measures related to
limiting exposure to mosquito bites, if the CDC recommended undertaking them, more than 75%
of the participants answered positively. On the other hand, less than half of them believed in their
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ability to follow the advice regarding protection against sexual transmission (30.4% & 45%)
(Figure 16).

Information Sources and Information Needs
Television and Radio were the most reported sources of respondents’ information about Zika,
while only a minority of them reported getting their information directly from healthcare
professionals. Interestingly, the group of respondents who received their information directly
from healthcare professionals included a higher percentage of younger respondents (18-38 years
of age) than participants from older age groups (Figure 17). Also, compared to participants with
other levels of education, a higher proportion of respondents with post-graduate degrees reported
healthcare professionals as one of their information sources about Zika (Figure 18). There were
no differences in the distribution of reported information sources between female and male
participants (Figure 19).
Finally, with regard to the topics about which participants wanted to learn more information,
routes of transmission, symptoms, treatment, complications, and prevention of Zika infection
were all selected with similar frequencies by the participants (Figure 20).
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Inferential Statistics
Knowledge Scores in Different Demographic Groups

Introduction
To determine if the age, gender, educational level, the presence of women of child-bearing age
and of pregnant women in the household were associated with significant differences in
participants’ knowledge scores, the mean knowledge scores for each category of these
demographic groups were compared.

Approach
Comparison of the mean knowledge scores among different age groups was made using Analysis
of Variance (ANOVA), while Independent sample t-tests were used to compare other
demographic categories.
Prior to the analysis, the assumptions of normality and homogeneity of variance were assessed.
A Shapiro-Wilk test was used to determine whether Knowledge scores followed a normal
distribution[74].
The results of the Shapiro-Wilk test were significant, W = 0.97, p < .001. This suggests that
knowledge scores are unlikely to have been produced by a normal distribution; thus, normality
cannot be assumed. However, according to the Central Limit Theorem (CLT), deviations from
normality will have little effect on the results with a sufficiently large sample size (n > 50) [75].
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Levene's test was used to assess whether the homogeneity of variance assumption was met [76].
The homogeneity of variance assumption requires the variance to be approximately equal in each
category of the independent variable groups. The only demographic item in which this
assumption was violated was the (GENDER) item. For this item, Welch's t-test was used instead
of the Student's t-test, as the former is more reliable when the two categories of the independent
variable have unequal distributions [77].

Results
Age:
The results of the ANOVA were significant, F(2, 497) = 15.35, p < .001, indicating that there
were significant differences in knowledge scores among the different age groups (Table 2).
To further examine the differences, t-tests were calculated between each pair of age groups.
Tukey pairwise comparisons were conducted for all significant effects. The mean of knowledge
score for the (18-38) age group was significantly smaller than the mean score for the other age
groups. The means and standard deviations are presented in (Table 3).

Gender:
The result of the independent samples t-test was not significant, t (491.93) = -1.67, p = .095,
indicating that the null hypothesis cannot be rejected. This suggests that the mean knowledge
score was not significantly different between female and male participants. (Table 4) presents the
results of the independent samples t-test.
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Education Level:
The result of the independent samples t-test was significant, t(498) = -3.19, p = .001, indicating
that the null hypothesis can be rejected. The mean knowledge score for participants with college
degrees was significantly higher than the mean for participants with lower educational levels.
(Table 5) presents the results of the independent samples t-test.

The Presence of Women of Child-Bearing Age in the Household:
The result of the independent samples t-test was not significant, t(498) = 0.52, p = .606,
indicating that participants’ knowledge scores were not significantly affected by the presence of
women of child-bearing age in the household. (Table 6) presents the results of the independent
samples t-test.

The Presence of Pregnant Women in the Household:
The result of the independent samples t-test was significant, t(498) = 3.69, p < .001. The
presence of pregnant women in the household was associated with a significantly lower mean
knowledge score. (Table 7) presents the results of the independent samples t-test.

18

Assessing the Association between the Frequency of Protective Behavior Undertaking and
Participants' Perceptions about the Severity and Personal Susceptibility to Zika Infection

Introduction
To assess whether differences in the reported frequency of protective behavior undertaking were
associated with differences in respondents’ perceptions of the seriousness and/or of their
personal susceptibility to Zika infection, the mean scores of the (perception of severity) and
(Perception of susceptibility) questions were compared between participants who reported
frequent undertaking of the protective measures and other participants.

Approach
First, Participants were divided into two groups: Those who frequently undertook the protective
measures (Selected the answer choices OFTEN or ALWAYS), and other respondents. Then, the
mean scores of the (Perception of Severity & Perception of Susceptibility) questions for the two
groups were compared using independent samples t-Tests.
The same methods described in the previous section were utilized for assumption testing and for
selecting the appropriate analytical approach.
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Results
The Association between the Frequency of Protective Behavior Undertaking and the Perception
of Zika Infection Severity:

The result of the independent samples t-test was not significant for any of the six protective
measures. This indicates that differences in the perception of Zika infection severity among
participants were not associated with significant differences in the frequency of their protective
behavior undertaking. (Table 8) summarizes the results of the independent samples t-tests.

The Association between the Frequency of Protective Behavior Undertaking and the Perception
of Susceptibility to Zika Infection:

The results of the independent samples t-test were significant for five of the six protective
behavior items. In contrast to other Participants, those who reported frequent undertaking of the
protective measures perceived a significantly higher personal susceptibility to the infection.
(Table 9) provides a summary of the results.
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Assessing the Association between the Frequency of Protective Behavior Undertaking and
Efficacy Beliefs
Introduction
The effect of efficacy beliefs on the adoption of the proposed protective measures was examined.
Efficacy beliefs included: Response efficacy beliefs, the degree to which the participant believes
that the proposed behavior can protect from contracting the infection (Q23), and Self-efficacy
beliefs, respondents’ beliefs about their ability to carry out the proposed measures (Q24).
Approach
For each of the six proposed protective measures, respondents were divided into two groups
based on whether they agreed that the behavior in question can be protective against Zika. The
same method was followed to create another dichotomous variable for the (Self-efficacy)
question. Then, efficacy beliefs for the group of respondents who reported frequent undertaking
of the proposed measures were compared to other respondents. This was achieved using Chisquare tests of association.
Prior to conducting the analysis, the assumption of adequate cell size was assessed, which
requires all cells to have expected values greater than zero and 80% of cells to have expected
values of at least five [78]. For each of the six protective measures, all cells had expected values
greater than zero, and a total of 100.00% of the cells had expected frequencies of at least five.
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Results
The Association between the Frequency of Protective Behavior Undertaking and Response
Efficacy Beliefs:
The results of the Chi-square test were significant in all the items, indicating that the frequency
of protective behavior undertaking was significantly associated with respondents’ beliefs about
the efficacy of the protective measures. (Table 10 to Table 15) present the results of the Chisquare tests.

The Association between the Frequency of Protective Behavior Undertaking and Self-Efficacy
Beliefs:
The results of the Chi-square tests indicated that there was a significant association between the
reported frequency of protective behaviors undertaking and respondents’ beliefs about their
ability to carry-out those behaviors. This result was observed for all the six protective behavior
items in the survey. (Table 16 to Table 21) summarize the results of the Chi-square tests.
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DISCUSSION

Knowledge assessment has revealed several patterns in participants’ misconceptions about Zika
infection. One of these patterns was in the items related to the transmission of the infection. For
instance, a large proportion of the respondents didn’t recognize the possibility of acquiring the
infection through sexual contact and via infected blood, while identifying the vector-borne
transmission route. A possible explanation for this might be related to the finding that media
platforms constituted the primary source of respondents’ information. Previous research has
found that most media reports about Zika didn’t address the non-vector-borne routes of
transmission [79, 80]. Another topic that was found to be excluded from discussion in the media
was the treatment of Zika symptoms, and our results revealed significant misconceptions in that
area as well [80]. Also, media coverage was mostly focused on the negative consequences of
Zika infection during pregnancy [80]. This might help in explaining our finding that a large
proportion of participants didn’t recognize the possibility of acquiring the infection and
developing complications in other age groups and in males.
Another potential example for the effect of information sources on respondents’ knowledge is
the significantly higher knowledge scores for participants with college education when compared
to participants with no college degrees. In contrast to other participants who reported media
platforms as their primary information source, healthcare professionals were the most frequently
reported source of information for respondents with college education. However, the higher
knowledge scores for older participants and participants with no pregnant women in the
23

household cannot be accounted for by the variance in information sources. A possible factor that
might help explaining the knowledge differences in these demographic groups could be the
socioeconomic status. Previous research has found a significant impact for participants’
socioeconomic status on their knowledge about other diseases [81, 82].
Attitudes toward protective behaviors are influenced by attitude-relevant knowledge [83].
A large proportion of respondents in our study didn’t identify sexual transmission as a route of
contracting Zika infection. Similarly, negative attitudes toward sexual protection measures were
observed among a large proportion of participants.
According to the Protection Motivation Theory (PMT), several cognitive processes mediate the
intention to follow a proposed protective behavior against a threat. These include: the perception
of the seriousness or severity of the threat, the perception of personal susceptibility to that threat,
the beliefs about the efficacy of the proposed behavior in neutralizing the threat, and selfefficacy beliefs, the extent to which a person believes that she/he can competently undertake the
behavior [84, 85]. This theory has been extensively used as a framework to understand the
determinants of protective health behavior. Meta-analyses of studies measuring PMT
components have revealed that all the components had significant effects on health behavior
intentions and undertaking [86, 87]. In this study, we found that the perceptions of susceptibility
to Zika infection, beliefs about the efficacy of the proposed behaviors and self-efficacy beliefs
were associated with significant differences in the frequency of protective behavior undertaking.
Because the survey was administered in the second half of 2017, we chose to assess the
frequency of undertaking of the protective behaviors rather than the intentions to engage in these
behaviors.
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Some limitations should be taken into account when interpreting the results of this research. For
instance, the method utilized for recruiting participants might have limited the representativeness
of the study sample to the general population of South Florida. To minimize the effect of the
sampling approach, we used quotas to ensure that the sample included participants of different
age groups, genders, and educational levels.
Another limitation of this study is the statistical analysis approach. While the statistical tests we
used (t-Tests, Chi-square, ANOVA) can assess whether a significant association was present
between two variables, they do not assess the strength of that relationship. Moreover, this
approach tests the effect of each independent variable on the dependent variable separately,
without considering the possible interaction between the multiple independent variables.
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CONCLUSION

The findings of this study suggest that more risk communication efforts are needed to increase
South Floridians' awareness about Zika's public health threat. Also, we identified some
demographic groups that would benefit from Zika awareness campaigns. Besides, the
identification of participants' preferred information sources and the factors that were associated
with more frequent adoption of the protective behaviors can aid in selecting the key risk
communication messages as well as in choosing the channels to deliver these messages.
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Figure 1: Respondents’ age
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Figure 2 : Respondent’s levels of education
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Figure 3 : Respondent groups based on the presence of pregnant women in the household
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Figure 4 : Respondent groups based on the presence of women of childbearing age (15-45) in the household
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Figure 5 : : Respondents’ answers to the question “Who can get infected with Zika?”
Green portions represent the percentages of participants with correct answers
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Figure 6 : Respondents’ answers to the question “How does a person get infected with Zika ?”
Green portions indicate the percentages of respondents with correct answers
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Figure 7 : Respondents’ answers to the question regarding Zika infection symptoms.
The green portion represents the percentage of participants with correct answers
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Figure 8 : Respondents’ answers to the questions regarding the treatment of Zika infections
Green portions indicate the percentages of respondents with correct answers
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Figure 9 : Respondents’ answers to the question regarding Microcephaly
The green portion represents the percentage of participants with correct answers
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Figure 10 : Respondents’ answers to the question regarding GBS
The green portion represents the percentage of participants with correct answers

37

Figure 11 : Respondents’ answers to the question regarding Zika vaccine availability
The green portion represents the percentage of participants with correct answers
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Figure 12 : Respondents’ answers to the question “On a scale from 1 to 10, how serious would it be for you to contract
the following disease(s) in the following year?”
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Figure 13 : Respondents’ answers to the question “"Suppose that you haven't taken any protective measures against Zika .
On a scale from 1 to 10,What do you think your chance of contracting the infection in the coming year is?
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Figure 14 : Distributions of Respondents’ reported frequencies of protective behavior undertaking
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Figure 15 : Responses to the statement “I believe that the following measure(s) can effectively protect against Zika infection:”
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Figure 16 : Responses to the statement “If recommended by the Centers for Disease Control, I'm confident that I will be able to take
the following measure(s):”
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Figure 17 : Reported sources of information about Zika for different age groups
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Figure 18 : Reported sources of information about Zika categorized by participants’ education levels
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Figure 19 : Reported sources of information about Zika for different genders
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Figure 20 : Respondents’ answers to the question “Regarding the current Zika outbreak, what are the most important topics
about which you want to receive information at this time?”
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Table 1 : Proportions of Participants with misconceptions about Zika

RESPONDENTS WITH
MISCONCEPTION(S)*

PROPORTION

Lower
95% CL

Lower
95% CL

Risk groups

358

0.716

0.675

0.754

Routes of
transmission

436

0.872

0.840

0.898

Symptoms

103

0.206

0.173

0.244

Treatment
(Antibiotic use)

209

0.418

0.376

0.462

Treatment
(NSAIDS use)

339

0.678

0.636

0.717

Complications
(Microcephaly)

64

0.128

0.102

0.160

171

0.342

0.302

0.385

197

0.394

0.352

0.437

Complications
(Guillain-Barre
syndrome)
Vaccination
availability
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Table 2 : Analysis of Variance Table for Knowledge score by Age group

Term

Sum of Squares

Age group

31.01

Degrees of
Freedom
2

Residuals

501.99

497

F

p

15.35

< .001

Table 3 : Means, Standard Deviations, and Sample Size for Knowledge score by Age group

AGE GROUP

M

SD

n

18-38

3.79

1.05

244

39-58

4.29

0.95

141

59-78

4.3

0.97

115

Table 4 : Independent Samples t-Test for the Difference in knowledge scores between Genders

MALES

FEMALES

Variable

M

SD

M

SD

t

p

d

Knowledge score

3.97

1.09

4.13

0.97

-1.67

.095

0.15

Note. Degrees of Freedom for the t-statistic = 491.93. d represents Cohen's d.
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Table 5 : Independent Samples t-Test for the Difference in Knowledge score by levels of education

OTHER
PARTICIPANTS
Variable
Knowledge score

M
3.86

PARTICIPANTS
WITH COLLEGE
DEGREES
M
SD
4.16
0.99

SD
1.08

t
- 3.19

p
.001

d
0.29

Note. Degrees of Freedom for the t-statistic = 498. d represents Cohen's d.

Table 6 : Independent Samples t-Test for the difference in knowledge scores by the presence of women
of childbearing age in the household

Women of childbearing age in the
household?
NO

YES

Variable

M

SD

M

SD

t

p

d

Knowledge score

4.08

1.11

4.03

0.98

0.52

.606

0.05

Note. Degrees of Freedom for the t-statistic = 498. d represents Cohen's d.

Table 7 : Independent Samples t-Test for the difference in knowledge scores by the presence of pregnant
women in the household

Pregnant women living in the
Household?
NO
YES
Variable

M

SD

M

SD

t

p

d

Knowledge score

4.11

1.03

3.55

0.91

3.69

< .001

0.57

Note. Degrees of Freedom for the t-statistic = 498. d represents Cohen's d.
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Table 8 : Independent Samples t-Tests for the association between the frequency of protective behavior undertaking
and respondents’ perception of Zika infection severity

FREQUENTLY
UNDERTOOK THE
PROTECTIVE
BEHAVIOR?
NO
VARIABLE

M

YES

SD

M

SD

t

p

d

USING MOSQUITO 6.30
REPELLENTS

3.17

6.49

3.13

-0.67

.503

0.06

Student’s t-Test

WEARING LONGSLEEVED
CLOTHES

6.41

3.10

6.28

3.28

0.43

.665

0.04

Student’s t-Test

CONDOM USE

6.36

3.17

6.41

3.12

-0.18

.855

0.02

Student’s t-Test

SEXUAL
ABSTINENCE

6.48

3.14

6.06

3.18

1.28

.202

0.13

Student’s t-Test

3.17

6.60

3.12

-1.86

.063

0.17

Student’s t-Test

3.18

6.59

3.12

-1.89

.059

0.17

Student’s t-Test

REMOVING
STAGNANT
6.07
WATER
FROM
SURROUNDINGS
AVOIDING
TRAVELLING TO
AREAS WITH
6.05
REPORTED
INFECTION CASES
Note. d represents Cohen's d.
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TEST USED

Table 9 : Independent Samples t-Tests for the association between the frequency of protective behavior undertaking
and respondents’ perception of personal susceptibility to Zika infection

FREQUENTLY
UNDERTOOK THE
PROTECTIVE
BEHAVIOR?
NO
VARIABLE

YES

M

SD

M

SD

USING MOSQUITO
REPELLENTS

3.81

2.29

4.34

2.56

-2.34

.020

0.22

Welch's t-test

WEARING LONGSLEEVED
CLOTHES

3.86

2.31

4.38

2.61

-2.06

.040

0.21

Welch's t-test

CONDOM USE

3.76

2.26

4.59

2.64

-3.39

<.001

0.34

Welch's t-test

SEXUAL
ABSTINENCE

3.88

2.32

4.39

2.63

-2.04

.042

0.21

Student’s t-Test

2.18

4.27

2.55

-2.88

.004

0.26

Welch's t-test

2.37

4.06

2.44

-0.63

.531

0.06

Student’s t-Test

REMOVING
STAGNANT
3.66
WATER
FROM
SURROUNDINGS
AVOIDING
TRAVELLING TO
AREAS WITH
3.93
REPORTED
INFECTION CASES
Note. d represents Cohen's d.
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t

p

d

TEST USED

Table 10 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for
(Using mosquito repellents/mosquito nets)

Believe that the behavior can be effective?
Frequently Undertook the
behavior?
No

No

Yes

107 [80]

203 [230]

Yes

22 [49]

168 [141]

Note. Χ2(1) = 32.37, p < .001. Items in brackets represent expected cell frequencies.

Table 11 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for
(Wearing long-sleeved clothes)

Frequently Undertook the
behavior?

Believe that the behavior can be effective?
No

Yes

No

141 [120]

215 [236]

Yes

27 [48]

117 [95]

Note. Χ2(1) = 19.99, p < .001. Items in brackets represent expected cell frequencies.

Table 12 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for
(Condom use)

Believe that the behavior can be effective?
Frequently Undertook the
behavior?
No

No

Yes

266 [234]

84 [116]

Yes

68 [100]

82 [50]

Note. Χ2(1) = 44.53, p < .001. Items in brackets represent expected cell frequencies.
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Table 13 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for
(Sexual abstinence)

Believe that the behavior can be effective?
Frequently Undertook the
behavior?
No

No

Yes

304 [270]

74 [108]

Yes

53 [87]

69 [35]

Note. Χ2(1) = 61.77, p < .001. Items in brackets represent expected cell frequencies.

Table 14 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for
(Removing stagnant water from surroundings/Covering water containers)

Believe that the behavior can be effective?
Frequently Undertook the
behavior?
No

No

Yes

81 [46]

135 [170]

Yes

25 [60]

259 [224]

Note. Χ2(1) = 60.48, p < .001. Items in brackets represent expected cell frequencies.

Table 15 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for
(Avoiding travel to areas where infection cases were reported)

Believe that the behavior can be effective?
Frequently Undertook the
behavior?
No

No

Yes

63 [36]

141 [168]

Yes

25 [52]

271 [244]

Note. Χ2(1) = 41.92, p < .001. Items in brackets represent expected cell frequencies.
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Table 16 : Chi-Square test of association between the frequency of undertaking and self- efficacy beliefs for (Using
mosquito repellents/mosquito nets)

Believes in his/her ability to undertake that behavior?
Frequently Undertook the
behavior?
No

No

Yes

76 [57]

234 [253]

Yes

16 [35]

174 [155]

Note. Χ2(1) = 20.32, p < .001. Items in brackets represent expected cell frequencies.

Table 17 : Chi-Square test of association between the frequency of undertaking and self- efficacy beliefs for
(Wearing long-sleeved clothes)

Believes in his/her ability to undertake that behavior?
Frequently Undertook the
behavior?
No

No

Yes

109 [87]

247 [269]

Yes

13 [35]

131 [109]

Note. Χ2(1) = 25.91, p < .001. Items in brackets represent expected cell frequencies.

Table 18 : Chi-Square test of association between the frequency of undertaking and self- efficacy beliefs for
(Condom use)

Believes in his/her ability to undertake that behavior?
Frequently Undertook the
behavior?
No

No

Yes

246 [193]

104 [158]

Yes

29 [83]

121 [68]

Note. Χ2(1) = 110.14, p < .001. Items in brackets represent expected cell frequencies.
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Table 19 : Chi-Square test of association between the frequency of undertaking and self-efficacy beliefs for (Sexual
abstinence)

Believes in his/her ability to undertake that behavior?
Frequently Undertook the
behavior?
No

No

Yes

309 [262]

69 [115.67]

Yes

38 [84.67]

84 [37]

Note. Χ2(1) = 111.19, p < .001. Items in brackets represent expected cell frequencies.

Table 20 : Chi-Square test of association between the frequency of undertaking and self-efficacy beliefs for
(Removing stagnant water from surroundings/Covering water containers)

Believes in his/her ability to undertake that behavior?
Frequently Undertook the
behavior?
No

No

Yes

64 [36]

152 [180]

Yes

20 [48]

264 [236]

Note. Χ2(1) = 44.78, p < .001. Items in brackets represent expected cell frequencies.

Table 21 : : Chi-Square test of association between the frequency of undertaking and self-efficacy beliefs for
(Avoiding travel to areas where infection cases were reported)

Believes in his/her ability to undertake that behavior?
Frequently Undertook the
behavior?
No

No

Yes

64 [33]

140 [171]

Yes

16 [47]

280 [249]

Note. Χ2(1) = 60.59, p < .001. Items in brackets represent expected cell frequencies.
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